A randomised controlled trial of the clinical effectiveness, safety and cost-effectiveness of adalimumab in combination with methotrexate for the treatment of juvenile idiopathic arthritis associated uveitis (SYCAMORE Trial)

Peer Review reports

Original Submission
9 Aug 2013	Submitted	Original manuscript
15 Aug 2013	Author responded	Author comments - Athimalaipet Ramanan
Resubmission - Version 2
15 Aug 2013	Submitted	Manuscript version 2
23 Oct 2013	Reviewed	Reviewer Report - Kelli Allen
22 Nov 2013	Author responded	Author comments - Athimalaipet Ramanan
Resubmission - Version 3
22 Nov 2013	Submitted	Manuscript version 3
Publishing
5 Dec 2013	Editorially accepted
9 Jan 2014	Article published	10.1186/1745-6215-15-14

Back to article page